View all News & Blog posts »
View all projects »
View all publications »
Interactive data visualizations of antibiotic use and resistance in North America and Europe
The Global Antibiotic Resistance Partnership (GARP) develops actionable policy proposals on antibiotic resistance for low- and middle-income countries. Proposals identify weaknesses in how antibiotics are developed, regulated, and managed, and how well countries track antibiotic use and resistance. Phase 1 of GARP encompassed work in four countries: India, Kenya, South Africa, and Vietnam. The expertise and capacity developed in these initial four countries is the core of a wider partnership involving other low- and middle-income countries to create greater awareness among national policymakers about the need for policies to control antibiotic resistance as part of a worldwide effort.
GARP is a project of the Center for Disease Dynamics, Economics & Policy. The GARP secretariat works collaboratively with partner organizations and national working groups in each focus country. Phase 2 of the project will include work in Mozambique, Tanzania, and two additional countries that are currently being identified to participate.
GARP Phase 1 culminated in the 1st Global Forum on Bacterial Infections: Balancing Treatment Access and Antibiotic Resistance on October 3-5, 2011, in New Delhi, India.